- Home
- MNOV vs SOL Comparison
MNOV vs SOL Comparison
Compare MNOV & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- SOL
- Stock Information
- Founded
- MNOV 2000
- SOL 2005
- Country
- MNOV United States
- SOL United States
- Employees
- MNOV N/A
- SOL N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- SOL Semiconductors
- Sector
- MNOV Health Care
- SOL Technology
- Exchange
- MNOV Nasdaq
- SOL Nasdaq
- Market Cap
- MNOV 76.0M
- SOL 84.6M
- IPO Year
- MNOV 2005
- SOL 2008
- Fundamental
- Price
- MNOV $1.41
- SOL $1.64
- Analyst Decision
- MNOV Strong Buy
- SOL Buy
- Analyst Count
- MNOV 1
- SOL 3
- Target Price
- MNOV $9.00
- SOL $3.50
- AVG Volume (30 Days)
- MNOV 13.2K
- SOL 646.6K
- Earning Date
- MNOV 05-08-2025
- SOL 03-13-2025
- Dividend Yield
- MNOV N/A
- SOL N/A
- EPS Growth
- MNOV N/A
- SOL N/A
- EPS
- MNOV N/A
- SOL N/A
- Revenue
- MNOV N/A
- SOL $92,067,000.00
- Revenue This Year
- MNOV N/A
- SOL N/A
- Revenue Next Year
- MNOV N/A
- SOL $45.37
- P/E Ratio
- MNOV N/A
- SOL N/A
- Revenue Growth
- MNOV N/A
- SOL N/A
- 52 Week Low
- MNOV $1.12
- SOL $1.04
- 52 Week High
- MNOV $2.55
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- MNOV 33.27
- SOL 51.82
- Support Level
- MNOV $1.44
- SOL $1.53
- Resistance Level
- MNOV $1.53
- SOL $1.73
- Average True Range (ATR)
- MNOV 0.05
- SOL 0.14
- MACD
- MNOV 0.01
- SOL 0.01
- Stochastic Oscillator
- MNOV 0.00
- SOL 78.95
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.